Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Macrogenics
(NQ:
MGNX
)
3.695
-0.005 (-0.14%)
Streaming Delayed Price
Updated: 9:58 AM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,453
Open
3.700
Bid (Size)
3.690 (7)
Ask (Size)
3.700 (1)
Prev. Close
3.700
Today's Range
3.670 - 3.720
52wk Range
2.951 - 21.88
Shares Outstanding
61,107,288
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Macrogenics Earnings Preview
November 04, 2024
Via
Benzinga
MacroGenics Announces Leadership Transition
October 30, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Performance
YTD
-63.70%
-63.70%
1 Month
+2.92%
+2.92%
3 Month
+3.21%
+3.21%
6 Month
-77.43%
-77.43%
1 Year
-32.08%
-32.08%
More News
Read More
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
October 29, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
October 22, 2024
From
TerSera Therapeutics LLC
Via
Business Wire
Macrogenics Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
September 18, 2024
Via
Benzinga
MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm
September 24, 2024
From
The Schall Law Firm
Via
Business Wire
MGNX DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 24 Deadline in Securities Class Action – MGNX
September 23, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
September 23, 2024
From
The Schall Law Firm
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm
September 21, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics
September 19, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm
September 17, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights
September 17, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline
September 16, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Investor Reminder (MGNX): Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. Investors of September 24, 2024 Deadline
September 16, 2024
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
September 15, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CAE, MacroGenics, Vicor, and American Airlines and Encourages Investors to Contact the Firm
September 13, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Faruqi & Faruqi Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 - MGNX
September 13, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Lead Plaintiff Deadline Quickly Approaching in MacroGenics, Inc. (MGNX) Class Action – Shareholders Should Contact Robbins LLP for Information
September 11, 2024
From
Robbins LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CAE, MacroGenics, Vicor, and American Airlines and Encourages Investors to Contact the Firm
September 09, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
MGNX INVETOR ALERT: Kirby McInerney LLP Reminds MacroGenics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
September 09, 2024
From
Kirby McInerney LLP
Via
GlobeNewswire
MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline
September 09, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
September 08, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics
September 06, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ROSEN, A RANKED AND LEADING FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX
September 04, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm
September 03, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.